A Study to Test How Kidney Problems Influence the Blood Concentrations of Efgartigimod
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to argenx
Related studies linked through entity extraction aliases.
Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS
- Status
- TERMINATED
- Phase
- PHASE2
ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of the Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome (pSS)
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1 Bioequivalence Study of Efgartigimod PH20 SC Administered Via a Prefilled Syringe Versus a Vial+Syringe Presentation in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014)
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients With Lupus Nephritis (ZL-1103-013)
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating Efgartigimod in Patients With Guillain-Barré Syndrome
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase 3 Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid
- Status
- TERMINATED
- Phase
- PHASE3
A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single and Multiple Ascending Doses of ARGX-119 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2/PHASE3
A Phase 2/3 Study of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults With Multifocal Motor Neuropathy
- Status
- COMPLETED
- Phase
- PHASE2
Immune Response to PNEUMOVAX 23 in Healthy Adults Receiving Efgartigimod IV
- Status
- COMPLETED
- Phase
- PHASE1
ITP Registry and Accompanying Biospecimen Collection
- Status
- RECRUITING
- Phase
- N/A
An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV in Patients With Generalized Myasthenia Gravis
- Status
- COMPLETED
- Phase
- PHASE3
Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3